ATE201828T1 - Verwendung eines cgrp antagonisten zur behandlung von flechten und pruritus und so erhaltene zubereitung - Google Patents
Verwendung eines cgrp antagonisten zur behandlung von flechten und pruritus und so erhaltene zubereitungInfo
- Publication number
- ATE201828T1 ATE201828T1 AT96400456T AT96400456T ATE201828T1 AT E201828 T1 ATE201828 T1 AT E201828T1 AT 96400456 T AT96400456 T AT 96400456T AT 96400456 T AT96400456 T AT 96400456T AT E201828 T1 ATE201828 T1 AT E201828T1
- Authority
- AT
- Austria
- Prior art keywords
- lichen
- pruritus
- preparation
- treatment
- cgrp antagonist
- Prior art date
Links
- 229940127597 CGRP antagonist Drugs 0.000 title 1
- 208000003251 Pruritus Diseases 0.000 title 1
- 239000003735 calcitonin gene related peptide receptor antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/225—Calcitonin gene related peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9503627A FR2732220B1 (fr) | 1995-03-28 | 1995-03-28 | Utilisation d'un antagoniste de cgrp pour traiter les lichens et les prurits et composition obtenue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201828T1 true ATE201828T1 (de) | 2001-06-15 |
Family
ID=9477497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96400456T ATE201828T1 (de) | 1995-03-28 | 1996-03-04 | Verwendung eines cgrp antagonisten zur behandlung von flechten und pruritus und so erhaltene zubereitung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5935586A (de) |
| EP (1) | EP0734728B2 (de) |
| JP (1) | JP3043610B2 (de) |
| AR (1) | AR001435A1 (de) |
| AT (1) | ATE201828T1 (de) |
| BR (1) | BR9601467A (de) |
| CA (1) | CA2172778C (de) |
| DE (1) | DE69613168T3 (de) |
| ES (1) | ES2159697T5 (de) |
| FR (1) | FR2732220B1 (de) |
| HU (1) | HUP9600764A3 (de) |
| MX (1) | MX9601151A (de) |
| PL (1) | PL313511A1 (de) |
| RU (1) | RU2152785C1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| JP2001233764A (ja) * | 2000-02-22 | 2001-08-28 | Hisamitsu Pharmaceut Co Inc | Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤 |
| US11517612B2 (en) | 2016-11-18 | 2022-12-06 | Nepsone Ehf | Methods of treating inflammatory skin disorders |
| ES2323170T3 (es) | 2002-08-12 | 2009-07-08 | Birkir Sveinsson | Uso de compuestos antagonistas del cgrp para el tratamiento de la psoriasis. |
| US8168592B2 (en) * | 2005-10-21 | 2012-05-01 | Amgen Inc. | CGRP peptide antagonists and conjugates |
| RS20080200A (en) | 2005-11-14 | 2009-07-15 | Rinat Neuroscience Corp., | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| EP3441087A1 (de) | 2008-03-04 | 2019-02-13 | Teva Pharmaceuticals International GmbH | Verfahren zur behandlung von chronischen schmerzen |
| US8623366B2 (en) | 2009-08-28 | 2014-01-07 | Labrys Biologics, Inc. | Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| HRP20240159T1 (hr) | 2014-03-21 | 2024-04-12 | Teva Pharmaceuticals International Gmbh | Antagonistička protutijela usmjerena protiv peptida povezanog s genom kalcitonina i postupci koji ih koriste |
| KR101593793B1 (ko) * | 2014-04-29 | 2016-02-12 | 한전케이피에스 주식회사 | 리프트 행거 및 그 리프트 행거를 사용하여 리프트를 설치하는 방법 |
| PE20191148A1 (es) | 2016-09-23 | 2019-09-02 | Teva Pharmaceuticals Int Gmbh | Tratamiento de la migrana refractaria |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9201425D0 (sv) * | 1992-05-06 | 1992-05-06 | Kabi Pharmacia Ab | Method and means for preventing constriction of the pupil in the eye |
| US5445823A (en) * | 1994-10-20 | 1995-08-29 | The Procter & Gamble Company | Dermatological compositions and method of treatment of skin lesions therewith |
-
1995
- 1995-03-28 FR FR9503627A patent/FR2732220B1/fr not_active Expired - Lifetime
-
1996
- 1996-03-04 AT AT96400456T patent/ATE201828T1/de not_active IP Right Cessation
- 1996-03-04 DE DE69613168T patent/DE69613168T3/de not_active Expired - Lifetime
- 1996-03-04 ES ES96400456T patent/ES2159697T5/es not_active Expired - Lifetime
- 1996-03-04 EP EP96400456A patent/EP0734728B2/de not_active Expired - Lifetime
- 1996-03-26 BR BR9601467A patent/BR9601467A/pt active Search and Examination
- 1996-03-27 CA CA002172778A patent/CA2172778C/fr not_active Expired - Lifetime
- 1996-03-27 JP JP8072772A patent/JP3043610B2/ja not_active Expired - Lifetime
- 1996-03-27 AR ARP960101927A patent/AR001435A1/es unknown
- 1996-03-27 RU RU96105824/14A patent/RU2152785C1/ru active
- 1996-03-27 MX MX9601151A patent/MX9601151A/es unknown
- 1996-03-27 PL PL96313511A patent/PL313511A1/xx unknown
- 1996-03-27 HU HU9600764A patent/HUP9600764A3/hu unknown
- 1996-03-28 US US08/620,805 patent/US5935586A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3043610B2 (ja) | 2000-05-22 |
| EP0734728B2 (de) | 2008-02-13 |
| EP0734728B1 (de) | 2001-06-06 |
| BR9601467A (pt) | 1998-03-31 |
| AR001435A1 (es) | 1997-10-22 |
| HUP9600764A2 (en) | 1997-06-30 |
| DE69613168D1 (de) | 2001-07-12 |
| CA2172778A1 (fr) | 1996-09-29 |
| CA2172778C (fr) | 2008-02-12 |
| RU2152785C1 (ru) | 2000-07-20 |
| JPH08268904A (ja) | 1996-10-15 |
| US5935586A (en) | 1999-08-10 |
| FR2732220B1 (fr) | 1997-04-25 |
| MX9601151A (es) | 1997-02-28 |
| DE69613168T3 (de) | 2009-03-05 |
| HUP9600764A3 (en) | 1998-03-02 |
| FR2732220A1 (fr) | 1996-10-04 |
| ES2159697T3 (es) | 2001-10-16 |
| ES2159697T5 (es) | 2008-07-01 |
| DE69613168T2 (de) | 2001-09-27 |
| EP0734728A1 (de) | 1996-10-02 |
| PL313511A1 (en) | 1996-09-30 |
| HU9600764D0 (en) | 1996-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69600399D1 (de) | Verwendung von einem CGRP Antagonist für dir Behandlung von Hauterythemen neurogenischen Ursprung und erhaltene Zubearbeitung | |
| DE69622074D1 (de) | Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien | |
| DE69830728D1 (de) | Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz | |
| ATE331522T1 (de) | Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum | |
| ATE256463T1 (de) | Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes | |
| NO962179L (no) | Fremgangsmåte for fremstilling av metallocen og anvendelse derav | |
| DE69505657D1 (de) | Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren | |
| DE69720463T2 (de) | Sulfonamid-derivate und ihre verwendung zur behandlung von zns-erkrankungen | |
| DE69332732D1 (de) | Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose | |
| DE69610070D1 (de) | Verfahren zum abfallfreien herstellen von absorptionskernen und davon abgeleitete gewebeähnliche absorbierende materialien | |
| DE69115921D1 (de) | Verfahren zur behandlung und verwendung von abfallstoffen | |
| DE3780972D1 (de) | Verwendung von spezifischen n-methyl-d-aspartat-rezeptor-antagonisten zur praevention und behandlung von neurodegeneration. | |
| ATA47690A (de) | Verfahren und vorrichtung zur bestimmung von gebrauchseigenschaften eines prothesenschaftes | |
| ATA11989A (de) | Mittel zur vorbeugung gegen und behandlung von parodontopathien | |
| ATE201828T1 (de) | Verwendung eines cgrp antagonisten zur behandlung von flechten und pruritus und so erhaltene zubereitung | |
| DE69635708D1 (de) | Tetrandrin zur behandlung von augenentzündungen | |
| DE69310303D1 (de) | Gerät zur topografischen Bestimmung anatomischer Oberflächen, insbesondere der Kornea | |
| DE69306915D1 (de) | Kombination zur Detektion von Weichgewebeanomalien | |
| DE69426848D1 (de) | Gerät zur Behandlung von lichtempfindlichen Materialien | |
| FI973254A0 (fi) | Menetelmä aminoetyylietanoliamiinin ja/tai hydroksietyylipiperatsiinin valmistamiseksi | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| DE69635977D1 (de) | Verfahren zur Bestimmung der therapeutischen Wirkung von Metalloproteinase-Verbindungen, neue Inhibitor-Verbindungen und deren therapeutische Verwendung | |
| ATE173620T1 (de) | Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| DE60027429D1 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |